New SARS-CoV-2 KP.2 variant defies vaccines with higher spread, study warns

In­dus­try group PhRMA plans to again sue over a pro­gram that the FDA au­tho­rized late last week to al­low Flori­da to be­gin bulk pre­scrip­tion drug

On Valen­tine’s Day, a non-opi­oid drug­mak­er un­veiled it­self af­ter near­ly five years of court­ing drug can­di­dates be­hind the scenes and work­ing qui­et­ly “on the heels” of